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Fine-tuning of the hydrophobicity of caffeic acid: studies on the 
antimicrobial activity against Staphylococcus aureus and Escherichia 
coli 
Mafalda Andradea¥, Sofia Benfeitob¥, Pedro Soaresb, Diogo Magalhães e Silvab, Joana Loureiroa, 
Anabela Borgesa,b,c, Fernanda Borgesb* and Manuel Simõesa* 
The increased bacterial multidrug resistance caused by inappropriate use and overuse of antimicrobials is a global concern. 
To circumvent this issue, a quest for the development of new active agents has been widely recognized. Some 
phytochemical products, produced by plants as part of their chemical defense strategies, are regarded as new stimulus to 
develop novel antimicrobials that are not as vulnerable as current drugs to bacterial resistance mechanisms. In this study, 
the antimicrobial activity and mode of action of caffeic acid (CAF) and a series of CAF alkyl esters was assessed against 
Escherichia coli and Staphylococcus aureus, with the aim of analyzing the influence of the alkyl ester side chain length on 
the activity. Minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), changes in 
physicochemical surface properties and intracellular potassium leakage were used as physiological indices for the 
antimicrobial mode of action. CAF alkyl esters were found to be effective antimicrobial agents against both bacteria. Their 
activity was directly dependent on their lipophilicity, which affected bacterial susceptibility, the physicochemical 
properties of the bacteria and the integrity of the membranes. E. coli was less susceptible than S. aureus to the action of 
the compounds. Longer alkyl side chains were more effective against the Gram-positive bacterium, while medium length 
alkyl side chain compounds were more effective against the Gram-negative bacterium. Caffeic acid derivatives are 
proposed to act as cell permeabilizers, inducing membrane alterations, causing rupture with potassium leakage, 
particularly on the Gram positive bacterium, and consequent cell death. 
1 Introduction 
Control of microbial growth is required in many microbiologically 
sensitive environments, especially when the conditions for their 
proliferation are favorable.
1
 For this purpose, antibacterial agents 
such as biocides and antibiotics are usually employed 
2,3
 and their 
selection differ by the extent of their pharmacological specificity 
and of their degree of mammalian toxicity. Antibiotics usually have 
a single biochemical target (i.e., a selective toxicity) and are used 
against bacterial infections in human beings and animals. On the 
other hand, biocides generally possess several distinct targets, with 
diverse susceptibilities (i.e., a broad spectrum of usage) and are 
often regarded as antiseptics (used externally on human skin), 
disinfectants (for surface sanitizing), and/or preservatives 
(incorporated in pharmaceutical, cosmetic or other types of 
products to prevent microbial contamination).
1,2,4
 However, these 
agents have been widely recognized as being used inappropriately, 
and constantly subjected to overuse, underuse and general misuse 
over the years. On bacteria, these type of mishandlings create a 
selective pressure for the development of bacterial resistance 
and/or multidrug resistance to these compounds, with resistance 
being transmitted within and between individuals.
2,5–8
 The 
emergence of resistant microorganisms is a global concern and has 
led to a quest for the search and development of new alternative 
antimicrobial products not so vulnerable as current drugs to 
bacterial resistance mechanisms.
7–10
 
Plants produce a vast array of secondary metabolites 
(phytochemicals), a number of which are commonly believed to be 
involved in chemical strategies to protect themselves against 
pathogen microbial attack of fungi, yeasts and bacteria.
11,12
 The use 
of phytochemicals as antimicrobial agents is at present considered a 
strategic approach to overpass the mentioned drawbacks because 
they not only have multiple and different modes of action from 
current antibiotics (posing a low risk for the development of 
resistance), but are also derived from natural sources presenting a 
green and safe status.
13,14
 Bacterial susceptibility to phytochemicals, 
especially phenolic compounds, have been studied by several 
authors and, in general, they present a promising antimicrobial 
profile.
8,9,15–22
 Polyphenols are the most important and abundant 
group of phytochemicals and can be found in diverse dietary 
products like vegetables, fruits, chocolates and beverages (as 
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coffee, tea or wine).
23–25
 Phenolic compounds can be divided into 
two main groups: flavonoids and non-flavonoids that include 
several chemical classes, such as flavonols, isoflavones, 
anthocyanins, phenolic acids.
24,26
 Phenolic acids are the most 
common non-flavonoid naturally occurring phenolics which contain 
two distinguishing constitutive carbon frameworks: the 
hydroxycinnamic (C6C3) and hydroxybenzoic (C6C1) structure. Only a 
minor fraction of phenolic acids exists in the free form. Instead, the 
majority are linked through ester, ether or acetal bonds either to 
structural components of the plant, larger polyphenols or smaller 
organic molecules (e.g., glucose, quinic acid). Particular attention is 
at present given to hydroxycinnamic acids due to their remarkable 
biological properties, including antimicrobial activity of broad 
spectrum.
24,26,27
 The antimicrobial mode of action of phenolic acids 
can be due to their ability to destabilize and permeabilize the 
cytoplasmatic membrane, inhibition of enzymes involved in radical 
generation and also the inhibition of the synthesis of nucleic acids 
of both Gram-negative and -positive bacteria.
8
 Caffeic acid (Fig. 1) is 
generally the most abundant hydroxycinnamic acid, representing 
between 75% and 100% of the total hydroxycinnamic acid content 
of diverse fruits and beverages.
24,28,29
  
The efficacy of phytochemicals as antimicrobials as well as their 
diversity provides a renewed interest towards the discovery of new 
antibacterial drugs, being a new hope to overcome the bacterial 
resistance problem
8,16
. They can constitute new scaffolds for drug 
discovery and development programs as they can be tailored for 
fine-tuning their drug-like properties and so replenish the antibiotic 
pipeline.
30-33
 In this context, a structure-antimicrobial activity 
relationship (SAR) study was carry out focused on caffeic acid 
(trans-3,4-dihydroxycinnamic acid, CAF) (Fig. 1), a phytochemical 
that has been shown to display interesting antibacterial activity,
9
 
and an homologous series (C2 to C10) of alkyl esters derivatives 
(Schemes 1 and 2). In addition, the study of the effects of the 
increment of CAF lipophilicity on the planktonic bacterial growth of 
Staphylococcus aureus and Escherichia coli was performed. Their 
effects on bacterial physicochemical properties and membrane 
integrity was also evaluated. 
2 Materials and methods 
2.1 Chemistry 
 
2.1.1 Reagents. Caffeic acid and all the other reagents were 
purchased from Sigma–Aldrich Química S.A. (Sintra, Portugal) and 
used without additional purification. The solvents were pro analysis 
grade and were acquired from Merck (Lisbon, Portugal). Thin-layer 
chromatography (TLC) was carried out on precoated silica gel 60 
F254 (Merck) with layer thickness of 0.2 mm. For analytical control, 
the following elution systems were used: dichloromethane, ethyl 
acetate, dichloromethane/methanol and petroleum ether/ethyl 
acetate in several proportions. The spots were visualized under UV 
detection (254 and 366 nm). Flash column chromatography was 
performed using silica gel 60 (0.040–0.063 mm) (Merck). Following 
the workup and after extraction, the organic phases were always 
dried over Na2SO4. Solutions were decolorized with activated 
charcoal, when necessary. Solvents were evaporated in a Buchi 
Rotavapor. 
 
2.1.2 Apparatus. 
1
H and 
13
C NMR spectra were acquired, at room 
temperature, on a Brüker Biospin GmbH 400 spectrometer 
operating at 400 and 100 MHz, respectively. Chemical shifts were 
expressed in δ (ppm) values relative to tetramethylsilane (TMS) as 
internal reference; coupling constants (J) were given in Hz. 
Assignments were also made from DEPT (Distortionless 
Enhancement by Polarization Transfer) (underlined values). Electron 
impact mass spectra (EI-MS) were acquired on a VG AutoSpec 
instrument; data were reported as m/z (% of relative intensity of 
the most important fragments). Microwave-assisted synthesis was 
performed in Biotage® Initiator Microwave Synthesizer. 
 
2.2 Synthesis of alkyl caffeates 
 
2.2.1 Synthesis of alkyl caffeates with short chain length. The 
synthetic procedure was adapted from Garrido et al.
34
 The cinnamic 
acid (1.0 g), the ethanol or butanol (30 mmol) and 2 drops of 
concentrated sulphuric acid were added to a glass vial (2-5 mL) that 
was then sealed. The system was heated 20 
0
C above the boiling 
point of the alcohol for 10 min in microwave reactor cavity under 
mechanical stirring. After cooling to room temperature, the crude 
products were extracted with ethyl acetate (3 × 10 mL) and washed 
with water (3 × 10 mL). The combined organic layers were dried 
with Na2SO4, filtered and solvent was evaporated. The resulting 
residues were purified by flash chromatography using silica gel as 
stationary phase and petroleum ether/ethyl acetate as eluent. 
 
trans-Ethyl 3-(3,4-dihydroxyphenyl)propenoate (CAFC2): 
Yield: 78%, 
1
H NMR (DMSO-d6): 1.23 (3H, t, J = 8.0 H(2’)), 4.14 
(2H, m, H(1’)), 6.25 (1H, d, J = 16.0 H(β)), 6.76 (1H, d, J = 8.0 
H(5)), 6.99 (1H, dd, J = 8.0; 2.0 H(6)), 7.04 (1H, d, J = 2.0 H(2)), 
7.46 (1H, d, J = 16.0 H(α)). 
13
C NMR (DMSO): 14.3 (C(2’)), 59.7 
(C(1’)), 114.1 (C(2)), 114.8 (C(α)), 115.7 (C(5)), 121.4 (C(6)), 
125.5 (C(1)), 144.9 (C(β)), 145.6 (C(3)), 148.4 (C(4)), 166.5 (CO). 
MS/EI m/z: 209 (M
+•, 30), 208 (100), 180 (33), 164 (23), 163 
(96), 136 (55), 135 (40), 134 (45), 117 (21), 89 (47), 77 (25), 63 
(24), 51 (23). 
 
trans-Butyl 3-(3,4-dihydroxyphenyl)propenoate (CAFC4): 
Yield: 80%, 
1
H NMR (CDCl3): 0.96 (3H, t, J = 7.4, H(4’)), 1.43 
(2H, m, H(3’)), 1.69 (2H, m, H(2’)), 4.21 (2H, t, J = 6.6, H(1’)), 
6.26 (1H, d, J = 16.0 H(β)), 6.88 (1H, d, J = 8.4 H(5)), 7.00 (1H, 
dd, J = 2.0; 8.4 H(6)), 7.11 (1H, d, J = 2.0 H(2)), 7.58 (1H, d, 
J=16.0 H(α)). 
13
C NMR (CDCl3): 13.8 (C(4’)), 19.2 (C(3’)), 30.8 
(C(2’)), 64.8 (C(1’)), 114.4 (C(2)), 115.4 (C(α)), 115.5 (C(5)), 
122.4 (C(6)), 127.4 (C(1)), 144.0 (C(3)), 145.3 (C(β)), 146.6 
(C(4)), 168.4 (CO).  MS/EI m/z: 236 (M
+•, 78), 180 (98), 163 
(100), 136 (43), 135 (26), 134 (30), 89 (27). 
 
2.2.2 Synthesis of alkyl caffeates with long chain length 
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2.2.2.1 Synthesis of malonic acid half esters. The synthetic 
procedure was adapted from Menezes et al.
35
 Equimolar quantities 
(10 mmol) of Meldrum’s acid and the appropriate long chain 
alcohols were refluxed in toluene (5 mL) for 4 h. After cooling the 
reaction to room temperature 10 mL of a saturated NaHCO3 
solution was added. The formation of white foam is instantly 
observed. The compounds were extracted with diethyl ether (3 × 10 
mL) acidified with HCl, washed with water (3 × 10 mL). The 
combined organic layers were dried with Na2SO4, filtered and 
solvent was evaporated. The malonic acid half esters were 
characterized and used in the next reaction without further 
purification. 
 
Monohexyl malonate (1): Yield 61%. 
1
H NMR(CDCl3): 0.89 (3H, 
t, J = 7.0 H(6’)), 1.33 (6H, m, H(3’)-H(5’)), 1.65 (2H, m, H(2’)), 
3.43 (2H, s, H(2)), 4.16 (2H, t, J = 6.6 H(1’)).
 13
C NMR(CDCl3): 
14.2 (C(6’)), 22.4 (C(5’)), 25.8 (C(4’)), 29.1 (C(3’)), 31.6 (C(2’)), 
41.5 (C(2)), 64.8 (C(1’)), 166.9 (C(3)), 170.5 (C(1)). 
 
Monooctyl malonate (2): Yield 48%. 
 1
H NMR(CDCl3): 0.89 (3H, 
t, J = 7.0 H(8’)), 1.30 (10H, m, H(3’)-H(7’)), 1.65 (2H, m, H(2’)), 
3.43 (2H, s, H(2)), 4.16 (2H, t, J = 6.6 H(1’)). 
13
C NMR(CDCl3): 
14.3 (C(8’)), 22.4 (C(7’)), 29.3 (C(5’)), 29.4 (C(4’)), 26.9 (C(3’)), 
29.2 (C(2’)), 32.3 (C(6’)), 41. 2 (C(2)), 64.7 (C(1’)), 166.8 (C(3)), 
169.9 (C(1)). 
 
Monodecyl malonate (3): Yield 55%. 
1
H NMR(CDCl3): 0.88 (3H, 
t, J = 6.8 H(10’)), 1.30 (14H, m, H(3’)-H(9’)), 1.65 (2H, m, H(2’)), 
3.43 (2H, s, H(2)), 4.16 (2H, t, J = 6.6 H(1’)). 
13
C NMR(CDCl3): 
14.0 (C(10’)), 22.7 (C(9’)), 25.7 (C(3’)), 28.8 (C(2’)), 29.2 (C(7’)), 
29.5 (C(4’)), 29.7 (C(5’)), 29.9 (C(6’)), 32.1 (C(8’)), 40.8 (C(2)), 
64.6 (C(1’)), 166.6 (C(3)), 168.4 (C(1)). 
 
2.2.2.2 Condensation of malonic acid half esters with 3,4-
dihydroxybenzaldehyde. The synthetic procedure was adapted 
from Menezes et al.
35
 Equimolar quantities (1.0 mmol) of the 
malonic acid half esters and the 3,4-dihydroxybenzaldehyde were 
added to cyclohexane (3-5 mL). Then, anhydrous pyridine (1 mmol) 
and β-alanine (1.6 mmol) were added and the mixture was refluxed 
for 6-10 h. After cooling the mixture in an ice bath, concentrated 
HCl was added dropwise. After pH neutralization the mixture was 
extracted with diethyl ether (3 × 10 mL) and water (3 × 10 mL). The 
organic layer was dried with Na2SO4, filtered and solvent was 
evaporated under vacuum. The residues were purified by flash 
chromatography using gradient elution (petroleum ether/ethyl 
acetate). 
 
trans-Hexyl 3-(3,4-dihydroxyphenyl)propenoate (CAFC6): 
Yield 69%. 
1
H NMR (DMSO-d6): 0.87 (3H, t, J = 7.0, H(6’)), 1.31 
(6H, m, H(3’)-H(5’)), 1.62 (2H, m, H(2’)), 4.10 (2H, t, J = 6.6 
H(1’)), 6.26 (1H, d, J = 15.6 H(β)), 6.76 (1H, d, J = 8.4 H(5)), 6.94 
(1H, dd, J = 2.0; 8.4 H(6)),  7.04 (1H, d, J = 2.0 H(2)),  7.47 (1H, 
d, J = 15.6 H(α)), 9.12 (1H, s, OH), 9.57 (1H, s, OH). 
13
C NMR 
(DMSO-d6): 14.4 (C(6’)), 22.5 (C(5’)), 25.6 (C(4’)), 28.7 (C(3’)), 
31.4 (C(2’)), 64.2 (C(1’)), 114.5 (C(2)), 115.3 (C(α)), 116.2 (C(5)), 
121.8 (C(6)), 126.0 (C(1)), 145.5 (C(β)), 146.0 (C(3)), 148.8 
(C(4)), 167.1 (CO). MS/EI m/z (%): 264 (M
+•, 80), 181 (30), 180 
(100), 163 (90), 136 (49), 135 (34), 89 (38). 
 
trans-Octyl 3-(3,4-dihydroxyphenyl)propenoate (CAFC8): 
Yield 53%. 
1
H NMR (DMSO-d6): 0.86 (3H, t, J = 7.0 H(8’)), 1.30 
(10H, m, H(3’)-H(7’)), 1.62 (2H, m, H(2’)), 4.10 (2H, t, J = 6.6 
H(1’)), 6.26 (1H, d, J = 15.6 H(β)),  6.76 (1H, d, J = 8.4 H(5)), 6.94 
(1H, dd, J = 2.0; 8.4 H(6)),  7.04 (1H, d, J = 2.0 H(2)),  7.47 (1H, 
d, J = 15.6 H(α)), 9.40 (2H, 2x s, 2xOH). 
13
C NMR (DMSO-d6): 
15.3 (C(8’)), 23.5 (C(7’)), 26.8 (C(6’)), 29.7 (C(5’)), 30.0 (C(4’), 
C(3’)), 32.6 (C(2’)), 65.1 (C(1’)), 115.4 (C(2)), 116.2 (C(α)), 117.1 
(C(5)), 122.7 (C(6)), 126.7 (C(1)), 146.4 (C(β)), 146.9 (C(3)), 
149.7 (C(4)), 168.0 (CO). MS/EI m/z: 292 (M
+•, 50), 181 (25), 
180 (100), 163 (70), 136 (30). 
 
trans-Decyl 3-(3,4-dihydroxyphenyl)propenoate (CAFC10): 
Yield 42%. 
1
H NMR (CDCl3): 0.88 (3H, t, J = 6.8 H(10’)), 1.32 
(14H, m, H(3’)-H(9’)), 1.70 (2H, m, H(2’)), 4.20 (2H, t, J = 6.6 
H(1’)), 6.27 (1H, d, J = 15.6 H(β)), 6.88 (1H, d, J = 8.4 H(5)), 7.01 
(1H, dd, J = 8.4; 2.0 H(6)), 7.12 (1H, d, J = 2.0 H(2)), 7.59 (1H, d, 
J = 15.6 H(α)). 
13
C NMR (CDCl3): 14.1 (C(10’)), 22.7 (C(9’)), 26.0 
(C(8’)), 28.7 (C(7’)), 29.3 (C(6’), C(5’)), 29.6 (C(4’), C(3’)), 31.9 
(C(2’)), 65.0 (C(1’)), 114.5 (C(2)), 115.5 (C(5), 115.6 (C(α)), 
122.4 (C(6)), 127.5 (C(1)), 143.9 (C(3)), 145.0 (C(β)), 146.4 
(C(4)), 168.1 (CO). MS/EI m/z (%): 320 (M
+•, 28), 180 (100), 163 
(47), 134 (22), 98 (24), 84 (24), 57 (40), 55 (34). 
 
2.3 Microbiological studies 
 
2.3.1 Microorganisms and chemical solutions. S. aureus CECT 976 
and E. coli CECT 434, obtained from the Spanish Type Culture 
Collection, were selected for this study. The bacteria were 
cryopreserved at -80 ⁰C, in a mixture of Mueller-Hinton broth 
(MHB, Merck) and 30% (v/v) glycerol and subcultured in Mueller-
Hinton agar (MHA), at 30 ⁰C for 24 h, before testing. Stock solutions 
of all tested compounds were prepared in dimethyl sulfoxide 
(DMSO, Fisher), under sterile conditions, and kept in the dark, at 
room temperature, for a maximum of two weeks. Serial dilutions of 
the stock solutions were prepared in DMSO, when needed. 
 
2.3.2 Evaluation of minimum inhibitory concentration (MIC) and 
minimum bactericidal concentration (MBC). Bacterial cells were 
grown overnight in MHB at 30 ⁰C and 120 rpm in a Sartorius 
Certomat® BS-1 (Portugal) incubator. Afterwards, an inoculum was 
taken and adjusted to an optical density (OD) of 0.1 ± 0.02 (OD600 
nm). MIC values were determined in sterile 96-well flat-bottomed 
polystyrene tissue culture microtiter plates (Orange Scientific, 
Belgium). In each well, a volume of 20 μL of compound’s solution 
was added to 180 μL of cell culture. All compounds were tested in a 
range of different concentrations to reach the MIC. Cell suspensions 
with DMSO and cell suspensions without caffeic acid and 
derivatives were used as negative controls. Ciprofloxacin (Sigma–
Aldrich Química S.A.) was used as positive control for MIC and MBC 
determination. The OD600 was measured at t = 0 h and at t = 24 h, 
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using a microtiter plate absorbance reader (Biotek Synergy HT), 
after incubation at 30 ⁰C and 120 rpm. The MIC was defined as the 
lowest concentration of tested compound at which no bacterial 
growth was detected.20,37 After MIC determination, a volume of 10 
µL of each concentration tested for MIC assessment was plated out 
on MHA. Plates were incubated at 30 ⁰C for 24 h and growth was 
visually inspected. The MBC was determined as the lowest 
concentration of compound in which total inhibition of growth on 
solid medium was observed (no colony forming units - CFU - were 
detected).
1
 
 
2.3.3 Characterization of bacterial surface hydrophobicity. 
Overnight cultures grown in MHB were centrifuged at 3202 g for 10 
min and washed twice with sterile saline solution (0.85% (w/v) 
NaCl, BDH Prolabo). Subsequently, the OD640 nm of the cell 
suspension was set to 0.4 ± 0.04. A volume of 45 mL of the cell 
suspension was added to 5 mL of each test compound (to a final 
concentration of 0.1 mM) and incubated for 1 h at 30 ⁰C and 120 
rpm. All compounds were tested at the same concentration, 
regardless their MIC and MBC. A negative control was prepared 
with DMSO. Bacterial lawns (i.e. homogeneous layers of cells) were 
then prepared according to Busscher et al.
38
 After exposure to the 
compounds, cell cultures were filtered into nitrocellulose sterile 
filters (47 mm of diameter and pore size of 0.45 μm; Advantec) and 
contact angle measurements were carried out according to Simões 
et al.
39
, by using the sessile drop contact angle method to 
determine the surface tension of the bacterial surfaces (at least 20 
determinations for each liquid and for each microorganism). The 
measurements were performed at room temperature using three 
different liquids of well-known surface tension components (two 
polar - ultrapure water and formamide - and one apolar - α-
bromonaphtalene; Sigma). Contact angles were automatically 
determined using an OCA 15 Plus (Dataphysics) video-based optical 
measurement instrument, which allowed image acquisition and 
data analysis. The values of the liquids surface tension components 
were taken from the literature.
40
 Hydrophobicity was assessed after 
contact angle measurements using the approach of van Oss et al.41, 
where the degree of hydrophobicity of a given surface (s) is 
expressed as the free energy of interaction between two entities of 
that surface, when immersed in water (w): ΔGsws. If the interaction 
between two entities is stronger than the interaction of each one of 
the entities with water, then ΔGsws>0 mJ m
-2
 and the surface of 
bacterial cells are considered hydrophobic. Contrariwise, if ΔGsws<0 
mJ m
-2
 the bacterial cell surfaces are hydrophilic. ΔGsws can be 
calculated from the surface tension components of the interacting 
entities: 
 
∆ = −2	
 −	


+ 4 	

 +	

 −
	

 −	

                                                                          (1) 
 
where γ
LW
 is the Lifshitz-van der Waals component of the surface 
free energy and γ
+
 and γ
-
 are the electron acceptor and electron 
donor parameters, respectively of the Lewis acid-base component 
(given by 
 = 2 × 	

	). The surface tension components can 
be determined by simultaneous resolution of three equations 
(accounting for the three different liquids used for measuring the 
contact angles) of the form: 
 
1 + cos 
 = 2	

 + 	

 + 	

          (2) 
 
where θ is the contact angle and γ
TOT
=γ
LW
γ
AB
. 
 
2.3.4 Evaluation of zeta potential. S. aureus and E. coli were 
incubated overnight in MHB at 30 ⁰C and under 120 rpm agitation. 
The cells were centrifuged twice at 3202 g for 10 min (at 25 ⁰C) and 
washed with sterile distilled water. The cell suspensions were 
adjusted to OD640 nm = 0.2 ± 0.02. A volume of 1.8 mL of this culture 
was added to 200 μL of test compound (to a final concentration of 
0.1 mM) and incubated for 1 h at 30 ⁰C and 120 rpm. A negative 
control was prepared with DMSO. The zeta potential of the 
bacterial suspensions was determined, according to the procedure 
described by Borges et al.
8
, using a Nano Zetasizer (Malvern 
Instruments) equipment, in carefully filled zeta potential cells 
(DTS1060, Malvern), at room temperature. 
 
2.3.5 Evaluation of potassium leakage. Bacterial suspensions of S. 
aureus and E. coli were prepared in MHB and incubated at 30 ⁰C 
under 120 rpm agitation. After overnight grow, the cells were 
centrifuged at 3202 g for 15 min and washed twice with sterile 
distilled water. The cell suspensions were adjusted to OD640 nm = 0.2 
± 0.02 and incubated for 1 h at 30 ⁰C and 120 rpm, in contact with 
each test compound (at a final concentration of 0.1 mM). A 
negative control was prepared with DMSO. A positive control was 
performed with benzyldimethyldodecylammonium chloride (Sigma–
Aldrich Química S.A.) according to Ferreira et al.
1 
The bacterial 
suspensions were then filtered in sterile cellulose nitrate membrane 
filters (pore size 0.2 μm) (Whatman, UK). Atomic absorption 
spectroscopy (conditions: flame air-acetylene; wavelength 769.9 
nm) were used for K+ titration in the filtered bacterial solutions, 
using a GBC ASS 932plus device with the GBC Avante 1.33 
software.
1
 
 
2.4 Statistical analysis. 
All experiments were carried out in triplicate with at least three 
repeats. The data was analyzed using the GraphPad Prism 5 
software. The mean and standard deviation within samples was 
calculated for all cases. To assess the statistical significance of the 
data, an unpaired Student’s t-test was used (confidence level ≥ 
95%); p<0.05 was considered statistically significant. 
2.5. Calculation of drug-likeness properties 
The parameters for drug-likeness were evaluated according to the 
Lipinski’s ‘rule-of-five’, using the MolinspirationWebME Editor  
[http://www.molinspiration.com]. 
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3 Results and discussion 
3.1 Chemistry 
The alkyl caffeates with short chain length (Scheme 1) were 
synthesized by a nucleophilic acyl substitution reaction often called 
Fischer esterification. Esterification of carboxylic acids by primary or 
secondary alcohols is conventionally carried out under catalytic 
conditions, namely with sulfuric acid, tosylic acid and Lewis acids. 
Despite being a reaction widely used in (bio)organic synthesis it has 
some disadvantages, including long reaction times, safety and 
hazardous environmental problems, tedious purification processes 
and average to low reaction yields.
34,42
 The use of microwave-
assisted organic synthesis over conventional reactions may offer a 
convenient solution to overpass some of the mentioned problems, 
allowing a reduction of reaction time and/or the amount of 
reagent/solvent. In our case, yields around 80% (20 min of reaction 
time) have been obtained for CAFC2 and CAFC4 using caffeic acid 
(CAF) as starting material and ethanol and butanol as reagent, 
respectively (Scheme 1). Compared with the classic Fisher 
esterification, microwave conditions significantly reduced the 
reaction time (10 min versus 5 hours to 5 days, if conducted at 
room temperature), increased the yields  and simplified the 
purification process.43,44 The same reaction was used to obtain the 
alkyl caffeates with long chain length (Scheme 2). However, due to 
purification problems, mainly related to the higher boiling points of 
the primary alcohols and low yields, a different synthetic strategy 
was envisaged. Alkyl caffeates (CAFC6, CAFC8 and CAFC10) have 
been synthesized in moderate yields by synthetic strategy 
encompassing two steps: a) the first one consists in the formation 
of monomalonate compounds (1-3) by heating Meldrum’s acid with 
the appropriate alcohols in toluene; b) in the second the 
condensation of malonate half esters to 3,4-
dihydroxybenzaldehyde, in the presence of dry pyridine and β-
alanine, was performed by a Verley-Doebner modification of 
Knoevenagel reaction.45 
 
3.2 Antibacterial activity of caffeic acid and its alkyl esters 
CAF and its alkyl esters (C2 to C10) were screened towards S. aureus 
CECT 976 and E. coli CECT 434 strains. Although esters with a higher 
chain length (C12, C14 and C16) have been synthesized, water 
solubility problems preclude their use. So, the study was performed 
only  with the compounds that present drug-like properties (Tables 
1 and 2). According to the Lipinski’s ‘rule-of-five’ most "drug-like" 
molecules must have logP ≤ 5, molecular weight ≤ 500, number of 
hydrogen bond acceptors ≤10, and number of hydrogen bond 
donors ≤ 5. Molecules violating more than one of these parameters 
may have problems with bioavailability, namely poor oral 
absorption or membrane permeability.
46,47
 
In general cafeic alkyl esters present drug-like properties, only 
CAF10 has its partion coefficient on boundary, possessing an 
adequate number of proton acceptor and proton donor groups to 
ensure efficient interaction with the hydrogen bonding groups of 
the receptors. The predictive topological polar surface area (TPSA) 
data allow concluding that they could have a good capacity for 
penetrating cell membranes (Tables 1 and 2). From the data one 
can notice that caffeic acid has not satisfactory properties to cross 
membranes effectively.  
The MIC and MBC data of CAF and its alkyl ester derivatives (C2-
C10) gathered along the study are shown in Table 2. Considering 
that lipophilicity is an important property for data interpretation 
the theoretical partition coefficients (clogP) were also calculated 
(Table 2). In general, for each bacterial strain, a clear tendency was 
observed: MIC or MBC values decreased with increasing length of 
the alkyl ester chain. A simple modification of the lipophilicity of 
CAF (see CAF vs CAFC2) caused a relevant MIC decrease. It must be 
stressed that the esterification process also preclude the ionization 
process of CAF to a carboxylate ion (-COOH pka1= 4.36) at the 
working pH. The data is in accordance with the results obtained by 
Merkl et al.
20
 using similar systems.  
In S. aureus, octyl (CAFC8) and decyl caffeates (CAFC10) presented 
the lowest MIC values. As observed in Fig. 2 (A and B) these alkyl 
lengths seem to represent the maximum threshold of the parabolic 
curve of antimicrobial activity vs lipophilicity described by Kubo et 
al.
17,18
 for gallic acid esters. The same tendency was observed from 
MBC data, as the maximum of antibacterial activity is observed for 
CAFC8 (Fig. 3A and 3B). 
The antibacterial activity of the compounds towards E. coli followed 
the same tendency as observed for S. aureus. MIC values decreased 
with the increasing alkyl length of the compounds. The maximum 
threshold of antimicrobial activity was also observed for CAFC8 and 
CAFC10 (Fig. 2A and 2B). MBC differed in several orders of 
magnitude from the MIC and showed a more prominent parabolic 
behavior than the one observed for S. aureus, with maximum 
antibacterial activity being achieved for CAFC4 (Fig. 3A and 3B). 
These data propose that E. coli viability (bactericidal effects) is more 
affected by the length of the alkyl side chain than growth inhibition 
(bacteriostatic effects). In general, E. coli was less susceptible than 
S. aureus to the action of caffeate alkyl esters, which is in 
accordance with the observations made by several authors for 
similar systems.
7,11,16
 This behavior is most likely explained by the 
fact that Gram-negative bacteria possess an outer membrane with 
a hydrophilic coating of lipopolysaccharides (LPS)
48
, creating a 
greater barrier to antimicrobial agents. Contrarily, Gram-positive 
bacteria do not have an outer membrane and the cell wall consists 
almost entirely of peptidoglycan.
49
 The activity seems to be also 
reliant on the presence of a catechol moiety as the analogues based 
on ferulic (trans-3-methoxy-4-hydroxycinnamic acid) or sinapic 
(trans-3,5-dimethoxy-4-hydroxycinnamic acid) acids did not display 
remarkable activity (data not shown). This particular behavior can 
be related with the antioxidant/prooxidant and iron chelating 
properties displayed by catechol cinnamic systems.
50 
The MIC values obtained in this study are in the range of those 
described in other works with CAF and related compounds as well 
as reviewed by Guzman et al.
31
 These compounds showed a broad 
spectrum of antimicrobial activity, with MIC values between 0.49-8 
mM and 0.12-6 mM against E. coli and S. aureus, respectivly. For 
instance, in a work performed by Parkar et al.
51
 the MIC of CAF 
against S. aureus and E. coli was 0.69 mM and 2.78 mM, 
respectively. In other studies, MIC values in the range of 0.16 to 
˃5.5 mM against E. coli were found.
52-55
 In the same way, other 
natural cinnamic acids, such as ferulic and sinapic, showed 
significant activity against S. aureus with MIC between 0.64 and 
0.55 mM, respectively. Similar values were found against E. coli 
with these compounds.
56 
Interesting antimicrobial activity was 
found in a study performed with caffeic acid phenethyl ester and 
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derivatives, where it was obtained MIC values ranging from 41 to 86 
µM against S. aureus, including strains of MRSA.
57
 
The MIC and MBC values of CAF and its alkyl esters were 
significantly higher than those of the positive control, ciprofloxacin 
(MIC = 7.5 × 10
-4
 mM and MBC = 1.8 × 10
-2
 mM for E. coli; MIC = 1.5 
× 10
-3
 mM and MBC = 1.8 × 10
-2
 mM for S. aureus) and comparable 
to the susceptibilities previous reported for E. coli and S. aureus.
58,59 
Neverthless, CAF and its alkyl esters can be considered 
antimicrobials. In fact, plant-derived compounds are routinely 
classified as antimicrobias on the basis of susceptibility tests that 
produce MIC in the range of 100 to 1000 μg/mL, orders of 
magnitude weaker than those of typical antibiotics produced by 
bacteria and fungi (MIC in the range of  0.01 to 10 μg/mL).
9,11
 
 
3.3 Effects of caffeic acid and alkyl esters on the physicochemical 
surface properties of bacterial cells 
The results on the hydrophobicity and other surface tension 
parameters (polar, apolar, electron acceptor and donor 
components) of S. aureus and E. coli strains in the absence and 
presence of CAF and its alkyl esters are depicted in Table 3. Both 
bacterial surfaces presented hydrophilic properties (ΔG
TOT
>0 mJ/m
2
) 
and this parameter was slightly changed due to the exposure to CAF 
and its alkyl esters. S. aureus surface hydrophilicity decreased in the 
presence of alkyl caffeates with exception of CAFC2 (p<0.05), where 
an increase was found. No significant variation of hydrophilicity 
values was observed for CAFC4 and CAFC6, when comparing with 
untreated cells (p>0.05). This reduction in the hydrophilic character 
was significant (p<0.05) for S. aureus exposed to CAFC8 and 
CAFC10. 
The surface of E. coli cells was changed with the exposure to the 
compounds tested. Their hydrophilic character decreased with the 
ester caffeates, with the minimum values attained for cells treated 
with CAFC6 and CAFC8. Exposure to CAFC10 did not show a 
significant effect on the cell surface hydrophobicity, when 
compared with the control. 
The apolar character of both bacteria (γ
LW
) was reduced with the 
increase of the lipophilicity of the compounds. The polar 
component (γ
AB
) showed a parabolic behavior for E. coli, increasing 
with the lipophilicity of the compounds tested, being the maximum 
obtained for cells treated with CAFC6. However, no significant 
changes in this parameter was found for S. aureus (p>0.05). The 
electron acceptor properties were also maximized for E. coli 
exposed to CAFC6 and minimized for S. aureus exposed to CAFC2, 
while CAFC8 and CAFC10 caused a reduction of the electron donor 
properties of both bacteria (p<0.05). The overall data on 
hydrophobicity and its components clearly demonstrate that the 
CAF and its alkyl esters derivatives interact with the bacterial 
surface. A similar mode of action was found by Borges et al.
8
 for 
ferulic and gallic acids. 
The surface charge of cells is frequently determined based on their 
zeta potential, which is calculated from their electrophoretic 
motility in the presence of an electric field, under defined pH and 
salt concentrations.
60
 When applying an electric field across a 
bacterial suspension, bacteria with non-zero zeta potential migrate 
towards the electrode of the opposite charge, with a velocity 
proportional to the magnitude of their zeta potential.
1
 The results 
obtained from zeta potential measurements with S. aureus and E. 
coli in the absence and presence of CAF and its alkyl esters are 
shown in Table 4. Bacterial cells normally present a negative surface 
charge, due to the presence of anionic groups in their membranes, 
such as carboxylate and phosphate groups.
61,62
 In the present study, 
zeta potential values of -30.9 mV and -22.6 mV were obtained for S. 
aureus and E. coli, respectively, without exposure to the 
compounds. Changes in the surface charge of S. aureus to less 
negative values were obtained after exposure to CAF and CAFC2. 
The highest change on surface charge, for E. coli, was caused by 
CAF. This effect was probably due to its ionization to a carboxylate 
ion (-COOH pka1= 4.36) at the working pH.
63
 In general, the other 
CAF alkyl esters did not change significantly the surface charge 
(p>0.05) of the selected bacteria. 
 
3.4 Effects of caffeic acid and its alkyl esters on the cell membrane 
integrity 
Potassium leakage is considered to be a good indicator of microbial 
cytoplasmatic membrane damage.
64
 In fact, the internal ionic 
environment of prokaryotic and eukaryotic cells is rich in potassium, 
which means that membranolytic events in bacteria (i.e., any 
impairment to the barrier between cytoplasm and the extracellular 
medium) generally cause release of this ion.
8,64
 Table 5 shows the 
effects of CAF and its alkyl esters on K
+
 release by E. coli and S. 
aureus. A significant increase in K
+
 release was detected for S. 
aureus exposed to CAFC6, CAFC8 and CAFC10. This indicates an 
alteration in the cytoplasmic membrane permeability. However, no 
significant K
+
 release was found due to exposure to CAF and alkyl 
ester derivatives (CAFC2 and CAFC4). K
+
 release by E. coli was found 
for cells treated with CAF, CAFC4, CAFC6 and CAFC10, even if at 
lower extents than for S. aureus, when comparing to the control. 
The application of benzyldimethyldodecylammonium chloride 
(positive control) at 0.2 mM caused K
+
 release of 1.6 ± 0.28 µg/mL 
and 2.8 ± 0.18 µg/mL for E. coli and S. aureus, respectively. This 
biocide is known to cause cellular disruption and loss of membrane 
integrity with consequent leakage of essential intracellular 
constituents, including K
+
.
1
 Therefore, comparing with the positive 
control, the overall data propose that alkyl caffeates inflicted 
damage on the bacterial membranes of both bacteria, with 
remarkable effects on S. aureus. Therefore, one can propose that 
these compounds may act as membrane permeabilizers, i.e. as 
antimicrobial agents that weaken the outer membrane of the cells, 
inducing changes on its permeability and, consequently, in the 
bacterial physicochemical characteristics.
63,64
 It is possible that the 
antimicrobial activity of alkyl caffeates is associated with a fine 
balance between affinity for the lipid bilayers of cell membranes 
and the ability to cause disruption of the membrane, which visibly 
differs from Gram-positive to Gram-negative bacteria (due to their 
different cell wall structure and composition) and is dependent on 
the length of the alkyl ester side chain. Therefore, it is proposed 
that in Gram-negative bacteria, smaller length alkyl ester chains 
might have a better lipophilicity balance, and thus, be more 
effective in crossing the LPS layer of the outer membrane.
48
 This in 
accordance with the results obtained for MBC and K
+
 leakage, 
where medium length CAF alkyl esters, such as CAFC4 and CAFC6, 
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were more effective as bactericidal agents and proven to cause 
more damage to the membrane integrity. It is also noteworthy that 
lower susceptibilities observed for Gram-negative bacteria, might 
also be credited to the fact that the outer membrane is an effective 
barrier.
17,49
 On the Gram-positive bacterium longer alkyl side chain 
compounds, such as CAFC8 and CAFC10, reveal to be the best 
bacterial growth inhibitors and the compounds that have a greater 
impact on destabilizing the membrane based on the results of 
MIC/MBC, hydrophobicity and K
+
 leakage. 
The selected compounds possess a head-and-tail structure, similar 
to an amphiphile. Amphiphiles are molecules which present both 
hydrophilic and hydrophobic parts, usually a long-chain alkyl 
group.
48
 In this case, the amphiphile properties of caffeic acid esters 
are associated with the presence of the phenolic groups 
(hydrophilic moiety) and the alkyl side chain (lipophilic tail)
15
, which 
contributes to the parabolic function attained when antimicrobial 
activity is plotted against lipophilicity.
15–18
 This biological behavior 
could be correlated with the cutoff phenomenon, very distinctive of 
amphiphilic substances: antimicrobial properties of amphiphiles 
tend to increase with increasing alkyl chain length till a limit (the 
cutoff effect). However, it must be stressed that the length 
increasing lead to a concomitant shrinkage of compounds solubility 
in aqueous media a fact that can be also related with the decrease 
of their antimicrobial activity.
48
 
4 Conclusions 
Plant-derived molecules may offer a groundbreaking green 
approach to the discovery of broad-spectrum antimicrobials. This 
study shows that CAF is an interesting scaffold for the development 
of antimicrobial agents. CAF alkyl esters were more effective than 
CAF in controlling bacterial growth of S. aureus and E. coli. The 
lipophilicity of the compounds influenced its activity. Longer alkyl 
side chain compounds appeared to be more effective in inhibiting 
bacterial growth of the Gram-positive bacterium, particularly CAFC8 
and CAFC10. Medium length alkyl side chain compounds were more 
effective against the Gram-negative bacterium, particularly CAFC4. 
These molecules had broad spectrum activity causing significant 
changes in cell surface hydrophobicity, charge and induced K
+
 
leakage, an effect more significant for S. aureus. Moreover, as some 
cinnamic derivatives, have demonstrated good efficacy in the 
treatment of patients with tuberculosis
65
, the CAF alkyl esters are of 
potential interest to be used against Mycobacterium tuberculosis. 
Indeed, cinnamic derivatives already revelead high potency and 
selectivity against this bacterium, with MIC only at micromolars.
66,67
  
In summary, the study reinforce the idea that phytochemicals can 
operate as scaffolds for the development of new chemical entities 
with antimicrobial activity. The results of the present study suggests 
that this class of compounds is worthy for further studies, namely 
the evaluation of their additive or synergistic action with the 
antibiotics currently in use for antimicrobial therapy. 
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Fig. 1 Chemical structure and IUPAC numbering of caffeic acid (CAF). 
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Fig. 2 (A) Comparison of antimicrobial activity of CAF and alkyl esters against S. aureus (○) and E. coli (●). The best 
curve fit was obtained with the Boltzmann equation y =3.9 – 6811.03/(1+exp (x+12.28)/1.55), R2 = 0.9197) by S. 
aureus and polynomial equation y = 2.011+0.359x-0.016 x2), R2= 0.6256) by E. coli. (B) Regression plots of 
log(1/MIC) towards S. aureus (○) and E. coli (●) for CAF and alkyl esters derivatives tested. 
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Figure 3 - (A) Comparison of antimicrobial activity of CAF and alkyl esters against S. aureus (○) and E. coli (●). The 
best curve fit was obtained with the Boltzmann equation y = 4.13 – 2.88/(1+exp (x-4.16)/2.03), R2 = 0.9176) by S. 
aureus and Gaussian equation y = 1.607+ 0.883 exp(-0.5(x-4.027)/1.305)2, R2 = 0.7591) by E. coli. Regression plots of 
log(1/MBC) towards S. aureus (○) and E. coli (●) for CAF and alkyl esters derivatives tested. 
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Table 1 Structural properties of caffeic acid and alkyl esters.  
 R 
Molecular 
weight 
(g/mol) 
 
n-ROTB TPSA 
(Å2) 
n-ON 
acceptors 
n-
OHNH 
donors 
 
Volume 
(Å3) 
Caffeic acid CAF  180.16 
4 
77.76 4 3 
154.50 
Caffeic 
alkyl esters 
CAFC2  
208.21 4 66.76 4 2 188.83 
CAFC4  
236.27 6 66.76 4 2 222.43 
CAFC6 
 
264.32 8 66.76 4 2 256.03 
CAFC8  
292.38 10 66.76 4 2 289.64 
CAFC10  
320.43 12 66.76 4 2 323.24 
a n-ROTB, number of rotable bonds; TPSA, topological polar surface area; n-ON, number of hydrogen bond 
acceptors; n-OHNH, number of hydrogen bond donors. The data was determined with Molinspiration calculation 
software  
  
Page 12 of 17RSC Advances
R
S
C
A
dv
an
ce
s
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
11
 Ju
ne
 2
01
5.
 D
ow
nl
oa
de
d 
by
 C
ar
le
to
n 
U
ni
ve
rs
ity
 o
n 
16
/0
6/
20
15
 0
7:
34
:3
7.
 
View Article Online
DOI: 10.1039/C5RA05840F
 Table 2 Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of caffeic acid 
(CAF) and its alkyl ester derivatives (CAFC2-C10) against S. aureus and E. coli. 
 
 S. aureus E. coli cLoga 
R 
MIC 
(mM) 
MBC 
(mM) 
MIC 
(mM) 
MBC 
(mM) 
 
Caffeic acid CAF  19.5 32.5 39 39 1.15 
Caffeic 
 alkyl esters 
CAFC2  0.4 6.5 0.4 13 1.75 
CAFC4  1.6 3.25 0.4 3.25 2.66 
CAFC6 
 
0.4 0.6 0.15 > 13 3.49 
CAFC8  0.1 0.1 0.1 > 19.5 4.33 
CAFC10  0.1 0.15 0.1 > 19.5 5.16 
aTheoretical estimated using ChemBioDraw Ultra 13.0 program. 
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Table 3 Surface tension parameters and hydrophobicity of E. coli and S. aureus exposed to caffeic acid (CAF) and its 
alkyl ester derivatives (CAFC2-C10) at 0.1 mM, for 1 h 
  Surface tension parameters (mJ/m2) 
ΔGTOT (mJ/m2) 
  γLW γAB γ+ γ- 
S. aureus 
Control 34.3 ± 1.2 21.5 ± 1.2 2.4 ± 0.3 47.6 ± 3.0 23.0 ± 3.5 
CAF 32.4 ± 2.2 23.5 ± 2.8 2.8 ± 0.6 49.2 ± 1.4 24.3 ± 0.7 
CAFC2 34.8 ± 0.7 18.0 ± 1.3 1.6 ± 0.2 50.0 ± 1.2 27.5 ± 1.4 
CAFC4 34.1 ± 1.6 20.8 ± 2.3 2.3 ± 0.5 47.9 ± 1.1 23.8 ± 1.8 
CAFC6 31.7 ± 0.3 22.0 ± 2.1 2.7 ± 0.5 46.2 ± 1.4 22.1 ± 2.0 
CAFC8 25.6 ± 4.4 17.2 ± 4.0 2.1 ± 0.9 38.0 ± 4.4 15.5 ± 4.9 
CAFC10 24.8 ± 2.0 18.9 ± 2.0 2.3 ± 0.7 39.7 ± 4.1 17.6 ± 5.5 
E. coli 
Control 32.7 ± 1.4 21.6 ± 2.6 2,2 ± 0.5 54.5 ± 1.8 31.3 ± 2.7 
CAF 31.1 ± 1.4 25.5 ± 2.1 3.1 ± 0.5 53.8 ± 0.4 28.6 ± 1.1 
CAFC2 30.1 ± 0.8 26.2 ± 1.5 3.3 ± 0.3 51.9 ± 1.0 26.4 ± 0.4 
CAFC4 29.9 ± 0.9 26.9 ± 1.3 3.4 ± 0.3 52.8 ± 0.2 27.1 ± 0.3 
CAFC6 24.0 ± 1.6 32.3 ± 1.3 5.1 ± 0.5 50.9 ± 1.0 23.1 ± 1.5 
CAFC8 22.6 ± 1.4 22.4 ± 4.8 3.2 ± 1.5 43.3 ± 4.4 16.8 ± 2.4 
CAFC10 24.0 ± 2.3 19.9 ± 6.0 2.2 ± 1.5 51.6 ± 4.0 34.7 ± 4.3 
ΔGTOT > 0 mJ/m2 – Hydrophilic; ΔGTOT < 0 mJ/m2 - Hydrophobic 
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Table 4 Effects of caffeic acid (CAF) and its alkyl ester derivatives (CAFC2-C10) in the surface charge of S. aureus and 
E. coli cells at 0.1 mM, for 1 h.  
 Zeta Potential (mV) 
 S. aureus E. coli 
Control -30.9 ±3.3 -22.6±6.2 
CAF -10.2±4.5 -11.8±3.0 
CAFC2 -16.4±2.8 -28.1±4.7 
CAFC4 -24.7±3.7 -17.4±3.2 
CAFC6 -28.3±1.3 -18.4±0.9 
CAFC8 -25.5±4.5 -20.5±0.8 
CAFC10 -27.0±5.6 -19.6±2.1 
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Table 5. K
+ concentration in the solution after exposure of E. coli and S. aureus cells to CAF and its alkyl ester 
derivatives (CAFC2-10) at 0.1 mM, for 1 h.  
 Concentration of K
+
 in solution (μg/mL) 
 S. aureus E. coli 
Control 0.904 ± 0.272 0.263 ± 0.001 
CAF 1.177 ± 0.305 0.417 ± 0.010 
CAFC2 0.845 ± 0.344 0.356 ± 0.092 
CAFC4 0.927 ± 0.280 0.447 ± 0.021 
CAFC6 2.770 ± 0.095 0.566 ± 0.081 
CAFC8 2.745 ± 0.035 0.348 ± 0.071 
CAFC10 2.789 ± 0.004 0.502 ± 0.370 
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Scheme 1 Synthesis of ethyl (CAFC2) and butyl (CAFC4) caffeate from caffeic acid (CAF). Reagents and conditions: 
alkyl alcohol, H2SO4, microwave irradiation, 20min. 
 
 
Scheme 2 Synthesis of long alkyl chain cinnamates (CAFC6, CAFC8, CAFC10) from monomalonates 1-3. (i) Meldrum's 
acid, toluene, reflux, 4h; (ii) 3,4-dihydroxybenzaldehyde, pyridine, β-aniline, cyclohexane, reflux 6-10h. 
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